Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices 12859 

Time: 10 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Jose H Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Digestive Sciences. 

Date: March 26, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Bonnie L. Burgess-Beusse, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1783, beusseb@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Pilot and 

Feasibility Clinical Research Studies in 

Digestive Diseases and Nurtrition 

Date: March 26, 2012. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Peter J Perrin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

0682, perrinp@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 24, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5046 Filed 3–1–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of an Interagency Pain 

Research Coordinating Committee 

(IPRCC) meeting. 

The meeting will feature invited 

speakers and discussion of committee 

business items including a report on the 

findings of the Institute of Medicine 

report Relieving Pain in America: A 

Blueprint for Transforming Prevention, 

Care, Education, and Research and a 

review of information gathered on 

federally-funded pain research. 

The meeting will be open to the 

public and accessible by live webcast 

and conference call. 

Name of Committee: Interagency Pain 

Research Coordinating Committee. 

Type of meeting: Open Meeting. 

Date: March 27, 2012. 

Time: 8:30 a.m. to 4:30 p.m. *Eastern 

Time*—Approximate end time. 

Agenda: The meeting will feature 

invited speakers and discussion of 

committee business items including a 

report on the findings of the Institute of 

Medicine report Relieving Pain in 

America: A Blueprint for Transforming 

Prevention, Care, Education, and 

Research and a review of information 

gathered on federally-funded pain 

research. 

Place: National Institutes of Health, 

Building 1, Wilson Hall, 1 Center Drive, 

Bethesda, MD 20892. 

Conference Call: Dial: 800–779–1482, 

Participant Passcode: 31855. 

Cost: The meeting is free and open to 

the public. 

Webcast Live http://videocast.nih. 

gov/. 

Registration: http://iprcc.nih.gov/. 

Pre-registration is recommended to 

expedite check-in. Seating in the 

meeting room is limited to room 

capacity and is on a first come, first 

served basis. 

Deadlines: Notification of intent to 

present oral comments: Friday, March 

16, 2012, by 5 p.m. ET 

Submission of written/electronic 

statement for oral comments: Tuesday, 

March 20, 2012, by 5 p.m. ET 

Submission of written comments: 

Thursday, March 22, 2012, by 5 p.m. ET 

Access: Medical Center Metro (Red 

Line) Visitor Information: http:// 

www.nih.gov/about/visitor/index.htm. 

Contact Person: Dr. Paul Scott, 

Director, Office of Science Policy and 

Planning, National Institute of 

Neurological Disorders and Stroke, NIH, 

31 Center Drive, Room 8A03, Bethesda, 

MD 20892, Phone: (301) 496–9271, 

Email: IPRCC 

PublicInquiries@mail.nih.gov. 

Please Note: Any member of the public 

interested in presenting oral comments to the 

Committee must notify the Contact Person 

listed on this notice by 5 p.m. ET on Friday, 

March 16, 2012, with their request to present 

oral comments at the meeting. Interested 

individuals and representatives of 

organizations must submit a written/ 

electronic copy of the oral statement/ 

comments including a brief description of the 

organization represented by 5 p.m. ET on 

Tuesday, March 20, 2012. 

Statements submitted will become a 

part of the public record. Only one 

representative of an organization will be 

allowed to present oral comments on 

behalf of that organization, and 

presentations will be limited to three to 

five minutes per speaker, depending on 

number of speakers to be accommodated 

within the allotted time. Speakers will 

be assigned a time to speak in the order 

of the date and time when their request 

to speak is received, along with the 

required submission of the written/ 

electronic statement by the specified 

deadline. If special accommodations are 

needed, please email the Contact Person 

listed above. 

In addition, any interested person 

may submit written comments to the 

IPRCC prior to the meeting by sending 

the comments to the Contact Person 

listed on this notice by 5 p.m. ET, 

Thursday, March 22, 2012. The 

comments should include the name 

and, when applicable, the business or 

professional affiliation of the interested 

person. All written comments received 

by the deadlines for both oral and 

written public comments will be 

provided to the IPRCC for their 

consideration and will become part of 

the public record. The meeting will be 

open to the public through a conference 

call phone number and webcast live on 

the Internet. Members of the public who 

participate using the conference call 

phone number will be able to listen to 

the meeting but will not be heard. If you 

experience any technical problems with 

the conference call or webcast, please 

call Operator Service on 301 496–4517 

for conference call issues and the NIH 

IT Service Desk at (301) 496–4357, toll 

free (866) 319–4357, for webcast issues. 

Individuals who participate in person 

or by using these electronic services and 

who need special assistance, such as 

captioning of the conference call or 

other reasonable accommodations, 

should submit a request to the Contact 

Person listed on this notice at least 

seven days prior to the meeting. 

As a part of security procedures, 

attendees should be prepared to present 

a photo ID during the security process 

to get on the NIH campus. For a full 

description, please see: http:// 

www.nih.gov/about/visitorsecurity.htm. 

Pre-registration is recommended. 

Seating will be limited to the room 

capacity and seats will be on a first 

come, first served basis, with expedited 

check-in for those who are preregistered. 


tkelley on DSK3SPTVN1PROD with NOTICES
12860 Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices 

Information about the IPRCC is 

available on the Web site: http:// 

iprcc.nih.gov/. 

Dated: February 24, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy . 

[FR Doc. 2012–5037 Filed 3–1–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Autism Centers of 

Excellence: Centers. 

Date: March 28–29, 2012. 

Time: 7:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Cathy J. Wedeen, Ph.D., 

Scientific Review Officer, Division of 

Scientific Review, OD, Eunice Kennedy 

Shriver National Institute of Child Health 

And Human Development, NIH, 6100 

Executive Blvd., Room 5B01–G, Bethesda, 

MD 20892, 301–435–6878, 

wedeenc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: February 24, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5031 Filed 3–1–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIDDK. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

NATIONAL INSTITUTE OF DIABETES 

AND DIGESTIVE AND KIDNEY 

DISEASES, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDDK. 

Date: April 5–6, 2012. 

Time: April 5, 2012, 8:30 a.m. to 3:15 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Conference 

Room 9S235, Bethesda, MD 20892. 

Time: April 6, 2012, 8:30 a.m. to 3:15 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Conference 

Room 9S235, Bethesda, MD 20892. 

Contact Person: James E. Balow, MD, 

Clinical Director, National Institute of 

Diabetes and Digestive and Kidney Diseases, 

National Institutes of Health, Building 10, 

Room 9N222, Bethesda, MD 20892–1818, 

301–496–4181, jimb@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: February 24, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5018 Filed 3–1–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Maternal and Child 

Health in Poor Countries: Evidence from 

Randomized Evaluations MIT. 

Date: March 19, 2012. 

Time: 2 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Carla T. Walls, Ph.D., 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Boulevard, Room 5B01, Bethesda, MD 

20892–7510, 301–435–6898, 

wallsc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 


tkelley on DSK3SPTVN1PROD with NOTICES